Antibody Partnering Terms and Agreements

1
Antibody Partnering Terms and Agreements  
One-Stop Shop for Business Information
2
Summary
The Antibody Partnering Terms and Agreements
report provides comprehensive understanding and
unprecedented access to the antibody partnering
deals and agreements entered into by the worlds
leading healthcare companies. The report
provides a detailed understanding and analysis of
how and why companies enter antibody partnering
deals. The majority of deals are discovery or
development stage whereby the licensee obtains a
right or an option right to license the licensors
antibody technology. These deals tend to be
multicomponent, starting with collaborative RD,
and commercialization of outcomes.
3
This report provides details of the latest
antibody agreements announced in the healthcare
sectors, coveringAntibodiesAntibody-drug
conjugatesMonoclonal antibodiesMurine
mAbChimeric mAbHumanized mAbHuman
aAbPolyclonal Antibodies
4
Understanding the flexibility of a prospective
partners negotiated deals terms provides
critical insight into the negotiation process in
terms of what you can expect to achieve during
the negotiation of terms. Whilst many smaller
companies will be seeking details of the payments
clauses, the devil is in the detail in terms of
how payments are triggered contract documents
provide this insight where press releases do
not.This report contains over 1,000 links to
online copies of actual antibody deals and
contract documents as submitted to the Securities
Exchange Commission by companies and their
partners. Contract documents provide the answers
to numerous questions about a prospective
partners flexibility on a wide range of
important issues, many of which will have a
significant impact on each partys ability to
derive value from the deal.
5
The initial chapters of this report provide an
orientation of antibody dealmaking and business
activities. Chapter 1 provides an introduction to
the report, whilst chapter 2 provides an overview
of the trends in antibody dealmaking since 2007,
including details of average headline, upfront,
milestone and royalty terms. Chapter 3 provides
a review of the leading antibody deals since
2007. Deals are listed by headline value, signed
by bigpharma, most active bigpharma, and most
active of all biopharma companies. Where the deal
has an agreement contract published at the SEC a
link provides online access to the contract.
6
Chapter 4 provides a comprehensive listing of the
top 50 bigpharma companies with a brief summary
followed by a comprehensive listing of antibody
deals, as well as contract documents available in
the public domain. Where available, each deal
title links via Weblink to an online version of
the actual contract document, providing easy
access to each contract document on
demand. Chapter 5 provides a comprehensive
listing of the top big biotech companies with a
brief summary followed by a comprehensive listing
of antibody deals, as well as contract documents
available in the public domain. Where available,
each deal title links via Weblink to an online
version of the actual contract document,
providing easy access to each contract document
on demand.
7
Table of Contents

• Introduction
• Trends in antibody dealmaking
• Leading antibody deals
• Big pharma antibody deals
• Leading big biotech antibody deals
• Antibody dealmaking directory
• By antibody type
• Antibody partnering resources

8
Related Reports

• Global Cancer Monoclonal Antibodies Pipeline
  Analysis
• Global Markets and Manufacturing Technologies for
  Protein Drugs - Focus on Cytokines and Monoclonal
  Antibodies
• Monoclonal Antibodies Market in Breast Cancer to
  2019 - Strong Uptake of Novel HER-2 Targeted
  Therapies to Drive Robust Growth
• The Engineered T-Cell Receptor in Fusion
  Proteins, Antibodies Cells Emerging
  Opportunities for the Biopharmaceutical Industry
• Competitor Analysis Staphylococcus aureus
  Vaccines and Therapeutics (Antibodies,
  Antibiotics, Anti-Infectives)

9
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and
  benchmarks.
• http//www.bharatbook.com/customResearch.asp

10
For More Information You Can Visit

• http//www.bharatbook.com/Healthcare-market-resear
  ch-reports/Antibody-Partnering-Terms-and-Agreement
  s.html

Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 For Live
Chat - http//bit.ly/19m3TU4
Follow/Like Us on-